Wednesday, March 25, 2015 11:00:23 AM
Vancouver, BC / TheNewswire / March 9, 2015: Valdor Technology International Inc. ("Valdor") (TSX-V: VTI) (OTC: VTIFF) (Frankfurt: VZAA) is pleased to report that the fifth legacy Canadian telecom has now acquired a Valdor 1:32 harsh environment splitter. Each of these five telecoms has acquired one or more of the splitters for examination in their labs and/or environmental chambers or for installation into their fibre networks. These telecoms, in combination, provide hardwired telephone service to more than 90% of the Canadian population. The Valdor splitters are specifically designed for the North American fibre-to-the-premises (FTTP) and fibre-to-the-curb (FTTC) markets.
The most recent "Canadian Census" reports there are 12,437,500 households in Canada. The most recent "Industry Canada SME Research and Statistics" reports there are 1,107,540 employer businesses in Canada. This is a total of about 13,500,000 sites throughout Canada to connect FTTx. A total of 423,000 1:32 splitters would be required to accommodate this market. If these splitters were to be installed over a ten year period at a (budget) price of $1,000 each, the Canadian annual market would be $42,300,000 for 42,300 splitters. According to the "Canadian Radio-television and Telecommunications Commission", effective 2013, Canadian market penetration of FTTP was 2.9% and FTTC was 23.5%. As end-users demand higher speeds in FTTx, the telecom with the highest quality network will gain the most market share.
http://web.tmxmoney.com/article.php?newsid=73988417&qm_symbol=VTI
Recent VTI News
- VTI gibt positive vorläufige 1-Jahres-Daten aus der klinischen PROTECT-Studie auf der Jahrestagung der American Academy of Optometry bekannt • Business Wire • 10/12/2023 10:55:00 PM
- VTI annonce des données provisoires positives à un an de l'essai clinique PROTECT lors de la réunion annuelle de l'American Academy of Optometry • Business Wire • 10/12/2023 09:46:00 PM
- VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial at American Academy of Optometry Annual Meeting • Business Wire • 10/12/2023 02:00:00 PM
- VTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director • Business Wire • 08/30/2023 06:47:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM